Lifecore Biomedical, Inc. \De\ (LFCR) Liabilities and Shareholders Equity (2011 - 2025)

Lifecore Biomedical, Inc. \De\'s Liabilities and Shareholders Equity history runs 15 years deep, the most recent figure standing at $239.3 million for Q2 2025.

• In Q2 2025, Liabilities and Shareholders Equity fell 5.76% year-over-year to $239.3 million; the TTM figure through May 2025 stood at $979.2 million (down 1.25% YoY), while the FY2025 annual figure was $239.3 million, down 5.76% from the prior year.
• Liabilities and Shareholders Equity for Q2 2025 stood at $239.3 million, up from $237.7 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $506.9 million in Q1 2021, with the low at $236.7 million in Q1 2023.
• The 5-year median for Liabilities and Shareholders Equity is $254.7 million (2024), against an average of $304.3 million.
• The sharpest annual moves came in 2021 and 2022: Liabilities and Shareholders Equity soared 71.0% in 2021, then sank 45.27% in 2022.
• Lifecore Biomedical, Inc. \De\'s Liabilities and Shareholders Equity stood at $421.3 million in 2021, then tumbled by 34.5% to $276.0 million in 2022, then retreated by 10.93% to $245.8 million in 2023, then gained by 3.89% to $255.4 million in 2024, then fell by 6.28% to $239.3 million in 2025.
• Business Quant data shows LFCR's Liabilities and Shareholders Equity at $239.3 million in Q2 2025, $237.7 million in Q1 2025, and $255.4 million in Q4 2024.